{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T11:17:07Z","timestamp":1764587827129},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,4]],"date-time":"2016-10-04T00:00:00Z","timestamp":1475539200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s12020-016-1129-9","type":"journal-article","created":{"date-parts":[[2016,10,4]],"date-time":"2016-10-04T13:36:05Z","timestamp":1475588165000},"page":"231-238","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Long-term outcome of multimodal therapy for giant prolactinomas"],"prefix":"10.1007","volume":"55","author":[{"given":"Paula","family":"Andujar-Plata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocio","family":"Villar-Taibo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Dolores","family":"Ballesteros-Pomar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Vidal-Casariego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bego\u00f1a","family":"P\u00e9rez-Corral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Manuel","family":"Cabezas-Agr\u00edcola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"\u00c1lvarez-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram\u00f3n","family":"Serramito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Bernabeu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,4]]},"reference":[{"issue":"4","key":"1129_CR1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/cen.12242","volume":"79","author":"AB Moraes","year":"2013","unstructured":"A.B. Moraes, C.M. Dos Santos Silva, L. Vieira Neto, M.R. Gadelha, Giant prolactinomas: the therapeutic approach. Clin. Endocrinol. (Oxf.) 79(4), 447\u2013456 (2013)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"2","key":"1129_CR2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1530\/EJE-06-0646","volume":"156","author":"I Shimon","year":"2007","unstructured":"I. Shimon, C. Benbassat, M. Hadani, Effectiveness of long-term cabergoline treatment for giant prolactinoma: study of 12 men. Eur. J. Endocrinol. 156(2), 225\u2013231 (2007)","journal-title":"Eur. J. Endocrinol."},{"key":"1129_CR3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1530\/EJE-14-0013","volume":"170","author":"D Maiter","year":"2014","unstructured":"D. Maiter, E. Delgrange, Therapy of endocrine disease: the challenges in managing giant prolactinomas. Eur. J. Endocrinol. 170, 13\u201327 (2014)","journal-title":"Eur. J. Endocrinol."},{"key":"1129_CR4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/qjmed\/hcr221","volume":"106","author":"S Dash","year":"2013","unstructured":"S. Dash, A.K. Annamalai, H.L. Simpson, N. Sarkies, N.M. Antoun, R. Mannion, Acute shrinkage of a giant prolactinoma, masquerading as an erosive skull base tumour. QJM. 106, 85 (2013)","journal-title":"QJM"},{"issue":"2","key":"1129_CR5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3171\/jns.2002.97.2.0299","volume":"97","author":"RK Shrivastava","year":"2002","unstructured":"R.K. Shrivastava, M.S. Arginteanu, W.A. King, K.D. Post, Giant prolactinomas: clinical management and long-term follow up. J. Neurosurg. 97(2), 299\u2013306 (2002)","journal-title":"J. Neurosurg."},{"issue":"5","key":"1129_CR6","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1046\/j.1365-2265.2003.01770.x","volume":"58","author":"SM Corsello","year":"2003","unstructured":"S.M. Corsello, G. Ubertini, M. Altomare, R.M. Lovicu, M.G. Migneco, C.A. Rota, C. Colosimo, Giant prolactinomas in men: efficacy of cabergoline treatment. Clin. Endocrinol. (Oxf.) 58(5), 662\u2013670 (2003)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"1129_CR7","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1210\/jcem.82.4.3845","volume":"82","author":"ME Molitch","year":"1997","unstructured":"M.E. Molitch, M.O. Thorner, C. Wilson, Management of prolactinomas. J. Clin. Endocrinol. 82, 996\u20131000 (1997)","journal-title":"J. Clin. Endocrinol"},{"key":"1129_CR8","first-page":"989","volume":"87","author":"G Chiro Di","year":"1962","unstructured":"G. Di Chiro, K.B. Nelson, The volume of the sella turcica. Am. J. Roentgenol Radium Ther. Nucl. Med. 87, 989\u20131008 (1962)","journal-title":"Am. J. Roentgenol Radium Ther. Nucl. Med."},{"key":"1129_CR9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/00004728-199207000-00004","volume":"16","author":"P Lundin","year":"1992","unstructured":"P. Lundin, F. Pedersen, Volume of pituitary macroadenomas: assessment by MRI. J. Comput. Assist. Tomogr. 16, 519\u2013528 (1992)","journal-title":"J Comput Assist. Tomogr."},{"key":"1129_CR10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11102-005-5079-0","volume":"8","author":"A Ciccarelli","year":"2005","unstructured":"A. Ciccarelli, A.F. Daly, A. Beckers, The epidemiology of prolactinomas. Pituitary 8, 3\u20136 (2005)","journal-title":"Pituitary"},{"issue":"2","key":"1129_CR11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","volume":"96","author":"S Melmed","year":"2011","unstructured":"S. Melmed, F.F. Casanueva, A.R. Hoffman, D.L. Kleinberg, V.M. Montori, J.A. Schlechte, J.A. Wass, Endocrine Society. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96(2), 273\u2013288 (2011)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"1129_CR12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3171\/jns.2006.104.1.54","volume":"104","author":"ZB Wu","year":"2006","unstructured":"Z.B. Wu, C.J. Yu, Z.P. Su, Q.C. Zhuge, J.S. Wu, W.M. Zheng, Bromocriptine treatment of invasive giant prolactinomas involving the cavernous sinus: results of a long-term follow up. J. Neurosurg. 104(1), 54\u201361 (2006)","journal-title":"J. Neurosurg."},{"key":"1129_CR13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1530\/EJE-13-0503","volume":"170","author":"E Delgrange","year":"2014","unstructured":"E. Delgrange, G. Raverot, M. Bex, P. Burman, B. Decoudier, F. Devuyst, U. Feldt-Rasmussen, M. Andersen, D. Maiter, Giant prolactinomas in women. Eur. J. Endocrinol. 170, 31\u201338 (2014)","journal-title":"Eur. J. Endocrinol."},{"key":"1129_CR14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s11102-014-0588-3","volume":"3","author":"MH Almalki","year":"2015","unstructured":"M.H. Almalki, B. Buhary, S. Alzahrani, F. Alshahrani, S. Alsherbeni, G. Alhowsawi, N. Aljohani, Giant prolactinomas: clinical manifestations and outcomes of 16 Arab cases. Pituitary 3, 405\u20139 (2015)","journal-title":"Pituitary"},{"issue":"2","key":"1129_CR15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11102-005-5111-4","volume":"8","author":"A Chattopadhyay","year":"2005","unstructured":"A. Chattopadhyay, A. Bhansali, S.R. Masoodi, Long-term efficacy of bromocriptine in macroprolactinomas and giant prolactinomas in men. Pituitary 8(2), 147\u2013154 (2005)","journal-title":"Pituitary"},{"issue":"5","key":"1129_CR16","doi-asserted-by":"crossref","first-page":"874","DOI":"10.3346\/jkms.2009.24.5.874","volume":"24","author":"EH Cho","year":"2009","unstructured":"E.H. Cho, S.A. Lee, J.Y. Chung, E.H. Koh, Y.H. Cho, J.H. Kim, C.J. Kim, M.S. Kim, Efficacy and safety of cabergoline as first line treatment for invasive giant prolactinoma. J. Korean Med. Sci. 24(5), 874\u2013878 (2009)","journal-title":"J. Korean Med. Sci."},{"issue":"2","key":"1129_CR17","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s12020-013-0093-x","volume":"46","author":"O Cooper","year":"2014","unstructured":"O. Cooper, A. Mamelak, S. Bannykh, J. Carmichael, V. Bonert, S. Lim, G. Cook-Wien, A. Ben-Shlomo, Prolactinoma ErbB receptor expression and targeted therapy for aggressive tumors. Endocrine 46(2), 318\u2013327 (2014)","journal-title":"Endocrine"},{"issue":"7","key":"1129_CR18","first-page":"2102","volume":"82","author":"E Delgrange","year":"1997","unstructured":"E. Delgrange, J. Trouillas, D. Maiter, J. Donckier, J. Tourniaire, Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study. J. Clin. Endocrinol. Metab. 82(7), 2102\u20132107 (1997)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"1129_CR19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0090-3019(01)00697-8","volume":"57","author":"G Minniti","year":"2002","unstructured":"G. Minniti, M.L. Jaffrain-Rea, A. Santoro, V. Esposito, L. Ferrante, R. Delfini, G. Cantore, Giant prolactinomas presenting as skull base tumors. Surg. Neurol. 57(2), 99\u2013103 (2002)","journal-title":"Surg. Neurol."},{"issue":"3","key":"1129_CR20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s11102-015-0702-1","volume":"19","author":"I Kreitschmann-Andermahr","year":"2016","unstructured":"I. Kreitschmann-Andermahr, S. Siegel, B. Kleist, J. Kohlmann, D. Starz, R. Buslei, M. Koltowska-H\u00e4ggstr\u00f6m, C.J. Strasburger, M. Buchfelder, Diagnosis and management of acromegaly: the patient\u2019s perspective. Pituitary 19(3), 268\u2013276 (2016)","journal-title":"Pituitary"},{"issue":"3","key":"1129_CR21","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s12020-015-0791-7","volume":"52","author":"E Espinosa","year":"2016","unstructured":"E. Espinosa, E. Sosa, V. Mendoza, C. Ram\u00edrez, V. Melgar, M. Mercado, Giant prolactinomas: are they really different from ordinary macroprolactinomas? Endocrine 52(3), 652\u2013659 (2016)","journal-title":"Endocrine"},{"issue":"1","key":"1129_CR22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11102-005-5087-0","volume":"8","author":"C Yu","year":"2005","unstructured":"C. Yu, Z. Wu, J. Gong, Combined treatment of invasive giant prolactinomas. Pituitary 8(1), 61\u201365 (2005)","journal-title":"Pituitary"},{"issue":"3","key":"1129_CR23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0090-3019(00)00171-3","volume":"53","author":"HH Oru\u00e7kaptan","year":"2000","unstructured":"H.H. Oru\u00e7kaptan, O. Senmevsim, O.E. Ozcan, T. Ozgen, Pituitary adenomas: results of 684 surgically treated patients and review of the literature. Surg. Neurol. 53(3), 211\u2013219 (2000)","journal-title":"Surg. Neurol."},{"key":"1129_CR24","doi-asserted-by":"crossref","unstructured":"I. Shimon, E. Sosa, V. Mendoza, Y. Greenman, A. Tirosh, E. Espinosa, V. Popovic, A. Glezer, M.D. Bronstein, M. Mercado, Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomas. Pituitary 19(4), 429\u2013436 (2016)","DOI":"10.1007\/s11102-016-0723-4"},{"key":"1129_CR25","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1530\/EJE-11-1000","volume":"166","author":"V Primeau","year":"2012","unstructured":"V. Primeau, C. Raftopoulos, D. Maiter, Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients. Eur. J. Endocrinol. 166, 779\u2013786 (2012)","journal-title":"Eur. J. Endocrinol."},{"key":"1129_CR26","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1530\/EJE-12-0236","volume":"167","author":"L Vroonen","year":"2012","unstructured":"L. Vroonen, M.L. Jaffrain-Rea, P. Petrossian, G. Tamagno, P. Chanson, L. Vilar, F. Borson-Chazot, L.A. Naves, T. Brue, B. Gatta, Prolactino-mas resistant to standard doses of cabergoline: a multicenter study of 92 patients. Eur. J. Endocrinol. 167, 651\u2013662 (2012)","journal-title":"Eur. J. Endocrinol."},{"issue":"10","key":"1129_CR27","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1210\/jc.2012-2245","volume":"97","author":"JD Machicado","year":"2012","unstructured":"J.D. Machicado, J.M. Varghese, P.R. Orlander, Cabergoline-induced pneumocephalus in a medically treated macroprolactinoma. J. Clin. Endocrinol. Metab. 97(10), 3412\u20133413 (2012)","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-1129-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-016-1129-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-1129-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T20:19:48Z","timestamp":1498335588000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-016-1129-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,4]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["1129"],"URL":"https:\/\/doi.org\/10.1007\/s12020-016-1129-9","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,4]]}}}